From: Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?
Strength of association
R-value
Validity proven
Lower limit of 95% CI ≥ 0.85
Unclear validity
R < 0.85 to > 0.7
Proven lack of validity
Upper limit of 95% CI ≤ 0.7